Initiation
|
Citi analyst Filippo… Citi analyst Filippo Falorni initiated coverage of 16 companies in the U.S. beverages and household products and personal care space. After a year of "outsized industry-wide price realization with limited elasticity impacts," structural sales growth differences in the group will become more evident with companies offering true pricing power and attractive country/category exposures "re-emerging as relative winners," the analyst tells investors in a research note. City says that while group valuations remain elevated after large outperformance in 2022, there are "compelling single-name opportunities in the space." It tells investors to focus on "high-quality names" that have de-rated on near-term temporary concerns, offer a gross margin improvement story with declining commodity prices and the ability to retain prior pricing. The firm's top Buy-rated picks are Colgate-Palmolive (CL), Procter & Gamble (PG), Constellation Brands (STZ), Coca-Cola (KO), Monster Beverage (MNST) and Estee Lauder (EL). Citi's Sell-rated names are Kimberly-Clark (KMB) and Brown-Forman (BF.B). The firm put Neutral ratings on PepsiCo (PEP), Church & Dwight (CHD), Keurig Dr Pepper (KDP), Coty (COTY), Boston Beer (SAM), Clorox (CLX), Molson Coors (TAP) and Newell Brands (NWL). From a pair-trade standpoint, it recommends to overweight Procter & Gamble and underweight Kimberly-Clark, as well as to overweight Colgate-Palmolive, underweight Kimberly-Clark. ShowHide Related Items >><< - 01/19/23
- Complexity Gaming renews partnership with Miller Lite
- 10/06/22
- Molson Coors announces new partnership with the Professional Pickleball Assoc
- 09/29/22
- Molson Coors expands agreement with Coca-Cola to develop Topo Chico Spirited
- 01/26/23
- Constellation Brands announces Locke to retire from board of directors
- 01/05/23
- Constellation Brands CEO: We're radically undervalued at this price point
- 01/05/23
- Constellation sees pricing actions in beer business to be 'more muted' in FY24
- 11/10/22
- Constellation Brands completes elimination of Class B Common Stock
- $335.01 /
-56.155 (-14.36%) - 02/16/23
- Boston Beer falls -14.6%
- 02/15/23
- Boston Beer falls 11% to $349.77 after FY23 EPS guidance misses estimates
- 01/17/23
- Marimed appoints Matt Truppo as VP, retail sales
- 12/12/22
- Boston Beer's TeaPot launches merchandise collaboration with Peace Collective
- 02/14/23
- Nelson Peltz's Trian buys Disney, cuts Sysco in Q4
- 01/19/23
- Procter & Gamble says 'on track' to deliver FY23 guidance
- 01/19/23
- Procter & Gamble says Q2 growth broad based across business units
- 01/19/23
- Procter & Gamble reports Q2 gross margin down 160 bps vs. a year ago
- 02/12/23
- Fly Intel: Top five weekend stock stories
- 02/09/23
- PepsiCo sees FY23 share repurchases approximating $1B
- 02/09/23
- PepsiCo focused on delivering at least $1B in productivity savings
- 02/09/23
- PepsiCo: Monitoring consumers' spending patterns, behaviors
- 02/10/23
- Newell Brands falls 7% to $13.57 after Q1, FY23 guidance miss estimates
- 02/10/23
- Newell Brands chairman to transition to new position, Robert Steele to succeed
- 01/23/23
- Newell announces restructuring and savings initiative, to reduce headcount in Q1
- 12/12/22
- Newell Brands appoints Mark Erceg as CFO
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 02/16/23
- Coca-Cola raises quarterly dividend to 46c from 44c per share
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 02/14/23
- Coca-Cola says gained value share in NARTD beverages in Q4, FY
- 02/14/23
- Coca-Cola reports Q4 global unit case volume down 1%, up 5% for FY
- $126.44 /
-1.305 (-1.02%) - 10/25/22
- Kimberly-Clark cuts FY22 CapEx view to $900M-$1B from $1B-$1.1B
- 09/26/22
- Hostess Brands hires Adrian Poretti as Chief Supply Chain Officer
- 09/22/22
- Kimberly-Clark and Fetch Rewards enter long-term partnership
- 09/09/22
- Kimberly-Clark appoints Tamera Fenske to Chief Supply Chain Officer
- 01/19/23
- Keurig Dr Pepper CFO buys $350K in common stock
- 01/10/23
- Keurig Dr Pepper CEO sells $4.5M in common stock
- 12/08/22
- Keurig Dr Pepper, Nutrabolt announce strategic partnership
- 12/05/22
- Keurig Dr Pepper names Dr. Karin Rotem-Wildeman as Chief R&D Officer
- 11/15/22
- Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder
- 11/15/22
- Estee Lauder to acquire TOM FORD brand
- 11/02/22
- Estee Lauder raises quarterly dividend 10% to 66c from 60c per share
- 11/01/22
- Mondelez announces three new members to senior management team
- 01/12/23
- Coty extends license agreement with Jil Sander
- 12/21/22
- Coty sells Lacoste fragrance license back to Lacost
- 12/20/22
- Coty and Hugo Boss announce renewal of license agreement
- 12/12/22
- Coty expands buyback program by $200M
- 02/03/23
- Clorox rises 9.6%
- 02/02/23
- Clorox sees FX headwinds a 2-point reduction to FY23 sales
- 02/02/23
- Clorox CEO says 'actions we are taking to rebuild margin are working'
- 02/02/23
- Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 02/08/23
- Third Point updates on Colgate-Palmolive, DuPont, PG&E positions
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 02/03/23
- Church & Dwight sees FY23 reported gross margin up 100-120 bps
- 02/03/23
- Church & Dwight raises quarterly dividend 4% to 27.25c per share
- 09/06/22
- Church & Dwight to acquire Hero Mighty Patch for $630M
- 01/12/23
- Brown-Forman names Larry Combs chief information officer
- 12/07/22
- Brown-Forman sees FY23 capital expenditures $190M-$210M
- 12/01/22
- Brown-Forman to name Marshall Farrer chief strategic growth officer
- 11/17/22
- Brown-Forman raises quarterly cash dividend 9% to 20.55c from 18.85c per share
- 02/16/23 Citi
- Colgate-Palmolive initiated with a Buy at Citi
- 01/31/23 Barclays
- Colgate-Palmolive price target lowered to $77 from $80 at Barclays
- 01/30/23 Deutsche Bank
- Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank
- 01/30/23 Morgan Stanley
- Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley
- 02/16/23 Citi
- Procter & Gamble initiated with a Buy at Citi
- 01/20/23 Stifel
- Procter & Gamble price target raised to $147 from $139 at Stifel
- 01/13/23 JPMorgan
- Procter & Gamble price target raised to $150 from $141 at JPMorgan
- 12/06/22 Deutsche Bank
- Procter & Gamble price target raised to $162 from $156 at Deutsche Bank
- 02/16/23 Citi
- Constellation Brands initiated with a Buy at Citi
- 01/31/23 Evercore ISI
- Constellation Brands price target raised to $260 from $250 at Evercore ISI
- 01/26/23 Wells Fargo
- Constellation Brands price target raised to $250 from $240 at Wells Fargo
- 01/09/23 Barclays
- Constellation Brands price target lowered to $278 from $288 at Barclays
- 02/16/23 Citi
- Coca-Cola initiated with a Buy at Citi
- 02/15/23 Wells Fargo
- Coca-Cola price target lowered to $68 from $70 at Wells Fargo
- 02/15/23 Morgan Stanley
- Coca-Cola price target raised to $70 from $68 at Morgan Stanley
- 12/20/22 Atlantic Equities
- Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities
- 02/16/23 Citi
- Monster Beverage initiated with a Buy at Citi
- 02/06/23 Stifel
- Red Bull co-founder's death could benefit Monster Beverage, says Stifel
- 01/18/23 BMO Capital
- Monster Beverage price target raised to $97 from $95 at BMO Capital
- 01/18/23 Evercore ISI
- Monster Beverage price target raised to $115 from $105 at Evercore ISI
- 02/16/23 Citi
- Estee Lauder initiated with a Buy at Citi
- 02/13/23 Piper Sandler
- Estee Lauder price target raised to $298 from $290 at Piper Sandler
- 02/06/23 Credit Suisse
- Estee Lauder price target raised to $305 from $215 at Credit Suisse
- 02/03/23 Deutsche Bank
- Estee Lauder price target raised to $300 from $290 at Deutsche Bank
- $126.44 /
-1.305 (-1.02%) - 02/16/23 Citi
- Kimberly-Clark initiated with a Sell at Citi
- 01/27/23 Barclays
- Kimberly-Clark price target lowered to $126 from $146 at Barclays
- 01/26/23 Deutsche Bank
- Kimberly-Clark price target lowered to $122 from $124 at Deutsche Bank
- 01/26/23 Wells Fargo
- Kimberly-Clark price target lowered to $125 from $135 at Wells Fargo
- 02/16/23 Citi
- Brown-Forman initiated with a Sell at Citi
- 12/09/22 Barclays
- Brown-Forman price target lowered to $67 from $73 at Barclays
- 12/08/22 RBC Capital
- Brown-Forman price target lowered to $66 from $70 at RBC Capital
- 12/08/22 Deutsche Bank
- Brown-Forman price target lowered to $72 from $73 at Deutsche Bank
- 02/16/23 Citi
- PepsiCo initiated with a Neutral at Citi
- 02/13/23 Barclays
- PepsiCo price target lowered to $187 from $197 at Barclays
- 12/07/22 Argus
- PepsiCo price target raised to $206 from $195 at Argus
- 02/16/23 Citi
- Church & Dwight initiated with a Neutral at Citi
- 02/13/23 Argus
- Church & Dwight cut to Hold at Argus amid weak sales of high-margin products
- 02/13/23 Argus
- Church & Dwight downgraded to Hold from Buy at Argus
- 02/07/23 Oppenheimer
- Church & Dwight added back to Top Pick status at Oppenheimer
- 02/16/23 Citi
- Keurig Dr Pepper initiated with a Neutral at Citi
- 01/26/23 JPMorgan
- Keurig Dr Pepper price target raised to $41 from $40 at JPMorgan
- 12/06/22 Deutsche Bank
- Keurig Dr Pepper price target raised to $39 from $38 at Deutsche Bank
- 10/31/22 Truist
- Keurig Dr Pepper downgraded to Sell from Hold at Truist
- 02/16/23 Citi
- Coty initiated with a Neutral at Citi
- 02/09/23 Deutsche Bank
- Coty price target raised to $12 from $11 at Deutsche Bank
- 01/31/23 Jefferies
- Bath & Body Works price target raised to $52 from $45 at Jefferies
- 01/13/23 JPMorgan
- Coty price target raised to $9 from $8 at JPMorgan
- $335.01 /
-56.155 (-14.36%) - 02/16/23 Citi
- Boston Beer initiated with a Neutral at Citi
- 02/16/23 RBC Capital
- Boston Beer price target lowered to $300 from $314 at RBC Capital
- 02/16/23 Roth MKM
- Boston Beer price target lowered to $276 from $282 at Roth MKM
- 02/16/23 Bernstein
- Boston Beer downgraded to Underperform from Market Perform at Bernstein
- 02/16/23 Citi
- Molson Coors initiated with a Neutral at Citi
- 02/07/23 Morgan Stanley
- Molson Coors assumed with an Equal Weight at Morgan Stanley
- 01/06/23 TD Cowen
- Molson Coors upgraded to Outperform from Market Perform at Cowen
- 01/03/23 Wells Fargo
- Wells Fargo downgrades Molson Coors to Underweight, lowers price target to $45
- 02/16/23 Citi
- Newell Brands initiated with a Neutral at Citi
- 02/14/23 Barclays
- Newell Brands price target lowered to $11 from $13 at Barclays
- 02/13/23 RBC Capital
- Newell Brands price target lowered to $15 from $17 at RBC Capital
- 02/13/23 Raymond James
- Newell Brands price target lowered to $17 from $18 at Raymond James
- 02/16/23 Citi
- Clorox initiated with a Neutral at Citi
- 02/06/23 Barclays
- Clorox price target lowered to $108 from $110 at Barclays
- 02/03/23 UBS
- Clorox price target raised to $140 from $129 at UBS
- 02/01/23 Jefferies
- Clorox price target raised to $145 from $140 at Jefferies
- 11/01/22
- Molson Coors reports Q3 EPS $1.32, consensus $1.36
- 01/05/23
- Constellation Brands sees FY23 comparable EPS $11.00-$11.20
- 01/05/23
- Constellation Brands reports Q3 comparable EPS $2.83, consensus $2.89
- 01/04/23
- Notable companies reporting before tomorrow's open
- $335.01 /
-56.155 (-14.36%) - 02/15/23
- Boston Beer sees FY23 GAAP EPS $6.00-$10.00, consensus $11.02
- 02/15/23
- Boston Beer reports Q4 GAA EPS (93c), consensus 70c
- 10/20/22
- Boston Beer narrows FY22 adj EPS view to $7.00 to $10.00 from $6.00-$11.00
- 10/20/22
- Boston Beer reports Q3 EPS $2.21, consensus $3.07
- 01/19/23
- Procter & Gamble raises FY23 sales growth outlook
- 01/19/23
- Procter & Gamble reports Q2 core EPS $1.59, consensus $1.59
- 01/18/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- PepsiCo sees FY23 core EPS $7.20, consensus $7.28
- 02/09/23
- PepsiCo sees FY23 core EPS growth 8%, consensus $7.28
- 02/09/23
- PepsiCo reports Q4 core EPS $1.67, consensus $1.65
- 02/08/23
- Notable companies reporting before tomorrow's open
- 02/10/23
- Newell Brands sees FY23 normalized EPS 95c-$1.08, consensus $1.42
- 02/10/23
- Newell Brands sees Q1 normalized EPS (6c)-(3c), consensus 23c
- 02/10/23
- Newell Brands reports Q4 normalized EPS 16c, consensus 11c
- 02/09/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 02/14/23
- Coca-Cola expects 6%-7% currency headwind to Q1 comparable EPS
- 02/14/23
- Coca-Cola sees FY23 organic revenue (non-GAAP) growth of 7%-8%
- 02/14/23
- Coca-Cola reports Q4 adjusted EPS 45c, consensus 45c
- 10/25/22
- Coca-Cola sees FY22 comparable EPS up 6%-7%, consensus $2.46
- $126.44 /
-1.305 (-1.02%) - 01/25/23
- Kimberly-Clark sees FY23 EPS up 2%-6% versus FY22 adjusted EPS
- 01/25/23
- Kimberly-Clark approves 1.7% increase in dividend to $1.18 per share
- 01/25/23
- Kimberly-Clark reports Q4 adjusted EPS $1.54, consensus $1.51
- 01/24/23
- Notable companies reporting before tomorrow's open
- 12/05/22
- Keurig Dr Pepper backs FY22 adjusted EPS growth in mid-single-digit range
- 10/27/22
- Keurig Dr Pepper backs FY22 adj. EPS up mid-single-digit range, consensus $1.69
- 10/27/22
- Keurig Dr Pepper reports Q3 adjusted EPS 46c, consensus 46c
- 10/26/22
- Notable companies reporting before tomorrow's open
- 02/02/23
- Estee Lauder sees FY23 adjusted EPS $4.87-$5.02, consensus $5.35
- 02/02/23
- Estee Lauder sees Q3 adjusted EPS 37c-47c, consensus $1.77
- 02/02/23
- Estee Lauder reports Q2 adjusted EPS $1.54, consensus $1.30
- 02/02/23
- Estee Lauder reports Q2 diluted EPS $1.09, consensus $1.30
- 02/08/23
- Coty raises FY23 adjusted EPS 35c-36c view from 32c-33c
- 02/08/23
- Coty reports Q2 adjusted EPS 22c, consensus 15c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22
- 02/02/23
- Clorox reports Q2 adjusted EPS 98c, consensus 65c
- 02/02/23
- Notable companies reporting after market close
- 11/01/22
- Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07
- 01/27/23
- Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B
- 01/27/23
- Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c
- 01/26/23
- Notable companies reporting before tomorrow's open
- 02/03/23
- Church & Dwight sees Q1 adjusted EPS 75c, consensus 79c
- 02/03/23
- Church & Dwight sees FY23 adjusted EPS growth 0%-4%, consensus $3.09
- 02/03/23
- Church & Dwight reports Q4 adjusted EPS 62c, consensus 60c
- 02/02/23
- Notable companies reporting before tomorrow's open
- 12/07/22
- Brown-Forman reports Q2 EPS 49c, consensus 55c
- 12/06/22
- Notable companies reporting before tomorrow's open
- 08/31/22
- Brown-Forman reports Q1 EPS 52c, consensus 47c
|